Abdelrahman M. Alsharif
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abdelrahman M. Alsharif has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Amelia B. Knochel
Department of Surgery, University of Arizona, Tucson, AZ, 1501 North Campbell Avenue, Tucson, AZ 85724-5066
2 shared publications- Dharshan Sivaraj
Department of Surgery, University of Arizona, Tucson, AZ, 1501 North Campbell Avenue, Tucson, AZ 85724-5066
2 shared publications - Geoffrey C. Gurtner
Department of Surgery, University of Arizona College of Medicine, Tucson, AZ 85724, USA
2 shared publications - Hudson C. Kussie
Department of Surgery, University of Arizona, Tucson, AZ, 1501 North Campbell Avenue, Tucson, AZ 85724-5066
2 shared publications Jonathan P. Yasmeh
Department of Surgery, University of Arizona, Tucson, AZ, 1501 North Campbell Avenue, Tucson, AZ 85724-5066
2 shared publications- Kellen Chen
Department of Surgery, University of Arizona College of Medicine, Tucson, AZ 85724, USA
2 shared publications
Latest Publications
- Open Access
- 15 April 2026
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (10) , 2872-2885.e3
Mechanotransduction unifies healthy nondiabetic wound healing over time by promoting a Cd14+/C1qa+ fibroblast subpopulation
- 15 April 2026
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (10) , 2872-2885.e3
Open AccessMechanotransduction unifies healthy nondiabetic wound healing over time by promoting a Cd14+/C1qa+ fibroblast subpopulation
- Open Access
- 21 October 2025
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 10 (6) , 1247-1262
Targeting circulating mechanoresponsive monocytes and macrophages to reduce fibrosis
In response to injury, a variety of different cells are recruited to sites of injury to facilitate healing. Recent studies have examined the importance of the heterogeneity of tissue resident fibroblasts and mechanical signalling pathways in healing and fibrosis. However, tissue repair and the inflammatory response also involves blood cells that are recruited from the circulation. Here we identify mechanoresponsive myeloid subpopulations present in scar and unwounded skin. We then modulate these subpopulations by manipulating mechanical strain in vivo and in vitro and find that specifically targeting myeloid mechanical signalling is sufficient to reduce the pro-fibrotic myeloid subpopulations and restore the native, anti-inflammatory subpopulations. In addition, myeloid-specific mechanotransduction ablation also downregulates downstream pro-fibrotic fibroblast transcriptional profiles, reducing scar formation. As inflammatory cells circulate and home to injury sites during the initial healing phases in all organs, focusing on mechanoresponsive myeloid subpopulations may generate additional directions for systemic immunomodulatory therapies to target fibrosis and other diseases across other internal organ systems.
- 21 October 2025
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 10 (6) , 1247-1262
Open AccessTargeting circulating mechanoresponsive monocytes and macrophages to reduce fibrosis
In response to injury, a variety of different cells are recruited to sites of injury to facilitate healing. Recent studies have examined the importance of the heterogeneity of tissue resident fibroblasts and mechanical signalling pathways in healing and fibrosis. However, tissue repair and the inflammatory response also involves blood cells that are recruited from the circulation. Here we identify mechanoresponsive myeloid subpopulations present in scar and unwounded skin. We then modulate these subpopulations by manipulating mechanical strain in vivo and in vitro and find that specifically targeting myeloid mechanical signalling is sufficient to reduce the pro-fibrotic myeloid subpopulations and restore the native, anti-inflammatory subpopulations. In addition, myeloid-specific mechanotransduction ablation also downregulates downstream pro-fibrotic fibroblast transcriptional profiles, reducing scar formation. As inflammatory cells circulate and home to injury sites during the initial healing phases in all organs, focusing on mechanoresponsive myeloid subpopulations may generate additional directions for systemic immunomodulatory therapies to target fibrosis and other diseases across other internal organ systems.